• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination

tetano

Editor, Senior Moderator
Nat Commun


. 2026 Mar 2.
doi: 10.1038/s41467-026-70202-y. Online ahead of print.
Epitope-spanning antigenic variation reprograms immunodominance and broadens immunity in sequential influenza vaccination

Xiu-Feng Wan[SUP] #[/SUP][SUP] 1 2 3 4 [/SUP], Minhui Guan[SUP] #[/SUP][SUP] 5 6 7 [/SUP], Pradeep Balamalaliyage[SUP] #[/SUP][SUP] 5 6 7 [/SUP], Hanqiao Chen[SUP] #[/SUP][SUP] 8 [/SUP], Kritika Prasai[SUP] #[/SUP][SUP] 5 7 9 [/SUP], Ana Alcala[SUP] #[/SUP][SUP] 5 6 7 [/SUP], John Driver[SUP] 5 7 10 [/SUP], Alicia K Olivier[SUP] 11 [/SUP], Weihong Gu[SUP] 5 7 10 [/SUP], Christina Frymire[SUP] 5 6 7 [/SUP], De Darling Melany Carvalho Madrid[SUP] 5 7 10 [/SUP], Cheng Gao[SUP] 5 7 9 [/SUP], Chengcheng Wang[SUP] 5 7 9 [/SUP], Tao Li[SUP] 12 [/SUP], Wikanda Tunterak[SUP] 5 6 7 [/SUP], Qiongying Yang[SUP] 5 6 7 [/SUP], Ashwin Ramesh[SUP] 5 6 7 [/SUP], Muzaffar Ali[SUP] 5 6 7 [/SUP], David Smith[SUP] 11 [/SUP], Lei Li[SUP] 13 [/SUP], Andrea J Sant[SUP] 14 [/SUP], Jun Hang[SUP] 12 [/SUP], Hang Xie[SUP] 15 [/SUP], Mingyi Zhou[SUP] 5 6 7 [/SUP], Yizhi Jane Tao[SUP] 8 [/SUP]


Affiliations
Abstract

Immune imprinting, in which prior antigenic exposures biases recall toward dominant epitopes, constrains the breadth and durability of influenza vaccine protection. Here we show that targeted variation across multiple hemagglutinin (HA) head sites (A, B, and D) between sequential A(H3N2) vaccines reprograms epitope hierarchy-redirecting recall toward conserved, subdominant head and stem epitopes. In a controlled ferret model mimicking imprinting-like recall in humans, antigenically distant priming accelerates neutralizing antibody induction, broadens reactivity, enhances cross-protection, and reduces viral shedding after drifted virus challenge. Epitope mapping and structural analysis confirms redirection toward conserved epitopes; single-cell transcriptomics and ELISpot assays reveal amplified germinal center B cell and Th1 responses. This "epitope hierarchy reshaping" links targeted antigenic variation to enhanced B cell competition, amplified T cell help, and improved viral control. This principle is likely applicable to vaccines against other rapidly evolving viruses where strong imprinting effects similarly limit immune breadth.


 
Back
Top Bottom